Drosophila functional screening of de novo variants in autism uncovers damaging variants and facilitates discovery of rare neurodevelopmental diseases

Paul C. Marcogliese(Baylor College of Medicine), Samantha L. Deal(Neurological Research Institute), Jonathan C. Andrews(Baylor College of Medicine), J. Michael Harnish(Baylor College of Medicine), Venkata Hemanjani Bhavana(Baylor College of Medicine), Hillary K. Graves(Baylor College of Medicine), Sharayu Jangam(Baylor College of Medicine), Xi Luo(Baylor College of Medicine), Ning Liu(Baylor College of Medicine), Danqing Bei(Baylor College of Medicine), Yu-Hsin Chao(Baylor College of Medicine), Brooke Hull(Baylor College of Medicine), Pei-Tseng Lee(Baylor College of Medicine), Hongling Pan(Baylor College of Medicine), Pradnya Bhadane(Baylor College of Medicine), Mei‐Chu Huang(Baylor College of Medicine), Colleen M Longley(Neurological Research Institute), Hsiao‐Tuan Chao(Baylor College of Medicine), Hyung-Lok Chung(Texas Medical Center), Nele A Haelterman(Baylor College of Medicine), Oguz Kanca(Baylor College of Medicine), Sathiyanarayanan Manivannan(Baylor College of Medicine), Linda Rossetti(Baylor College of Medicine), Ryan J. German(Baylor College of Medicine), Amanda Gerard(Baylor College of Medicine), Eva Maria Christina Schwaibold(Heidelberg University), Sarah Fehr(Praxis für Humangenetik Tübingen), Renzo Guerrini(Meyer Children's Hospital), Annalisa Vetro(Meyer Children's Hospital), Eleina England(Broad Institute), Chaya N. Murali(Baylor College of Medicine), Tahsin Stefan Barakat(Erasmus MC), Marieke F. van Dooren(Erasmus MC), Martina Wilke(Erasmus MC), Marjon van Slegtenhorst(Erasmus MC), Gaëtan Lesca(Université Claude Bernard Lyon 1), Isabelle Sabatier(Université de Lyon), Nicolas Chatron(Université Claude Bernard Lyon 1), Catherine A. Brownstein(Boston Children's Hospital), Jill A. Madden(Boston Children's Hospital), Pankaj B. Agrawal(Boston Children's Hospital), Boris Keren(Sorbonne Université), Thomas Courtin(Sorbonne Université), Laurence Perrin(Université Paris Cité), Melanie Brügger(Technical University of Munich), Timo Roser(Ludwig-Maximilians-Universität München), Steffen Leiz(München Klinik), Frédéric Tran Mau‐Them(Inserm), Julian Delanne(Inserm), Elena Sukarova-Angelovska(University Clinic of Traumatology), Slavica Trajkova(University of Turin), Erik Rosenhahn(Leipzig University), Vincent Strehlow(Leipzig University), Konrad Platzer(Leipzig University), Roberto Keller(Torino e-district), Lisa Pavinato(University of Cologne), Alfredo Brusco(Azienda Ospedaliera Citta' della Salute e della Scienza di Torino), Jill A. Rosenfeld(Baylor College of Medicine), Ronit Marom(Baylor College of Medicine), Michael F. Wangler(Baylor College of Medicine), Shinya Yamamoto(Baylor College of Medicine)
Cell Reports
March 1, 2022
Cited by 52Open Access
Full Text

Abstract

Individuals with autism spectrum disorder (ASD) exhibit an increased burden of de novo mutations (DNMs) in a broadening range of genes. While these studies have implicated hundreds of genes in ASD pathogenesis, which DNMs cause functional consequences in vivo remains unclear. We functionally test the effects of ASD missense DNMs using Drosophila through "humanization" rescue and overexpression-based strategies. We examine 79 ASD variants in 74 genes identified in the Simons Simplex Collection and find 38% of them to cause functional alterations. Moreover, we identify GLRA2 as the cause of a spectrum of neurodevelopmental phenotypes beyond ASD in 13 previously undiagnosed subjects. Functional characterization of variants in ASD candidate genes points to conserved neurobiological mechanisms and facilitates gene discovery for rare neurodevelopmental diseases.


Related Papers

No related papers found

Powered by citation graph analysis